Education
About Us
Working with TipRanks
Follow Us
Forian (FORA)
NASDAQ:FORA
FORA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.64 - $4.03
Previous CloseN/A
Volume6.00
Average Volume (3M)16.02K
Market Cap
$54.45M
Enterprise Value$32.51M
Total Cash (Recent Filing)$35.65M
Total Debt (Recent Filing)$6.83M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Nov 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding31,112,312
10 Day Avg. Volume21,650
30 Day Avg. Volume16,023
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.60
Enterprise Value/Revenue1.30
Enterprise Value/Gross Profit2.19
Enterprise Value/Ebitda-140.43
Forecast
1Y Price Target
$3.50Price Target Upside97.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Forian News
FORA FAQ
What was Forian’s price range in the past 12 months?
Forian lowest stock price was $1.64 and its highest was $4.03 in the past 12 months.
What is Forian’s market cap?
Forian’s market cap is $54.45M.
When is Forian’s upcoming earnings report date?
Forian’s upcoming earnings report date is Nov 06, 2025 which is in 75 days.
How were Forian’s earnings last quarter?
Forian released its earnings results on Aug 13, 2025. The company reported $0.007 earnings per share for the quarter, missing the consensus estimate of $0.02 by -$0.013.
Is Forian overvalued?
According to Wall Street analysts Forian’s price is currently Undervalued.
Does Forian pay dividends?
Forian does not currently pay dividends.
What is Forian’s EPS estimate?
Forian’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Forian have?
Forian has 31,112,312 shares outstanding.
What happened to Forian’s price movement after its last earnings report?
Forian reported an EPS of $0.007 in its last earnings report, missing expectations of $0.02. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Forian?
Currently, no hedge funds are holding shares in FORA
Forian Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.50 (97.74% Upside)
$3.50 (97.74% Upside)
Blogger Sentiment
Bullish
FORA Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.63%
12-Months-Change
Fundamentals
Return on Equity
-3.20%
Trailing 12-Months
Asset Growth
-16.97%
Trailing 12-Months
Company Description
Forian
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
FORA Company Deck
FORA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Forian's earnings call highlighted strong revenue growth and improved financial metrics, largely driven by the strategic acquisition of Kyber Data Science. Despite these positive developments, the company faces challenges such as a mixed spending environment and reliance on contract renewals. The sentiment is cautiously optimistic with strong growth but some risks ahead.View all FORA earnings summariesFORA Stock 12 Month Forecast
Average Price Target
$3.50
▲(97.74% Upside)
Technical Analysis
Ownership Overview
31.76% Insiders
2.94% Mutual Funds
8.93% Other Institutional Investors
54.12% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---